免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

STAR 阿波羅™ 地圖系統

K 號:K253733 · 2025-12-19

決定日期2025-12-19
產品代碼DQK
諮詢委員會履歷
決定相當於

器材摘要

STAR Apollo™ Mapping System is the device name listed in this FDA 510(k) record. The listed applicant is Rhythm AI, Ltd.. It received FDA 510(k) clearance on 2025-12-19 under 510(k) number K253733. The device is classified under product code DQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the STAR Apollo™ Mapping System?

STAR Apollo™ Mapping System is a medical device that received FDA 510(k) clearance on 2025-12-19. The listed applicant is Rhythm AI, Ltd.. The 510(k) number is K253733.

When did STAR Apollo™ Mapping System receive FDA 510(k) clearance?

STAR Apollo™ Mapping System received FDA 510(k) clearance on 2025-12-19, under 510(k) number K253733.

Who is the listed applicant for STAR Apollo™ Mapping System?

The FDA 510(k) record lists Rhythm AI, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for STAR Apollo™ Mapping System?

The FDA product code for STAR Apollo™ Mapping System is DQK.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Rhythm AI, Ltd. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:DQK)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑